SCHEMBL9588987

SCHEMBL9588987

CCC(C(=O)OCCN1CCN(CCOC(=O)C(CC)c2ccc(OC)c(OC)c2)CC1)c1ccc(OC)c(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC29A1 Q99808 3/20 0.49
KCNQ2 O43526 1/20 0.48
PAX8 Q06710 1/20 0.47
DRD3 P35462 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
LDHA P00338 1/20 0.43
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP2D6 P10635 1/20 0.42
POLB P06746 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9591277 0.99 PAX8 (0.48) SLC29A1KCNQ2PAX8DRD3SMN1; SMN2
SCHEMBL9588632 0.91 PAX8 (0.47) SLC29A1KCNQ2PAX8DRD3SMN1; SMN2
Hydrochloric Acid SCHEMBL9589390 0.90 PAX8 (0.48) SLC29A1KCNQ2PAX8DRD3SMN1; SMN2
SCHEMBL9588975 0.89 PAX8 (0.45) SLC29A1KCNQ2PAX8DRD3SMN1; SMN2
Hydrochloric Acid SCHEMBL9588913 0.88 PAX8 (0.47) SLC29A1KCNQ2PAX8DRD3SMN1; SMN2
SCHEMBL9588640 0.81 SLC29A1 (0.48) SLC29A1DRD3SMN1; SMN2KMT2AMEN1
SCHEMBL11582477 0.81 CA12 (0.52) KCNQ2SMN1; SMN2KMT2AMEN1LDHA
SCHEMBL9590105 0.80 ALDH1A1 (0.50) KCNQ2DRD3KMT2AMEN1ALDH1A1
SCHEMBL9588549 0.80 SLC6A4 (0.48)
Hydrochloric Acid SCHEMBL9589396 0.80 SLC29A1 (0.47) SLC29A1PAX8DRD3SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5190946-A Piperazine compounds restore sensitivity to drug resistant cancer cells HOFFMANN-LA ROCHE INC. (US) 1993-03-02 US claimed
EP-0443569-A2 Diamine derivatives and their use in oncology F. HOFFMANN-LA ROCHE AG (CH) 1991-08-28 EP claimed
US-5190946-A Piperazine compounds restore sensitivity to drug resistant cancer cells HOFFMANN-LA ROCHE INC. (US) 1993-03-02 US disclosed
EP-0443569-A2 Diamine derivatives and their use in oncology F. HOFFMANN-LA ROCHE AG (CH) 1991-08-28 EP disclosed